Compounds useful as reversible inhibitors of cysteine proteases
Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (I), (II), (Ia) and (Ib) further defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for making such novel compounds
Boehringer Ingelheim Pharmaceuticals, Inc.
C C A A C C A C C C A A A C C A A C C C A A C C A C C C C
C04B C07D A61P A61P C07D C07D A61P C07D C07D C07D A61P A61P A61P C07D C07D A61P A61P C07D C07D C07D A61P A61P C07D C07D A61P C07D C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Sanxing Michel Jose Yancey David Erick Richard Roush Eugene R. David S. Denice Mary Weimin
Sun Emmanuel Ward Young Hickey Thomson Spero Liu